Alterity Therapeutics
(ASX) ATH
Alterity Therapeutics Financials at a Glance
Market Cap
$97.88M
Revenue (TTM)
$7.56M
Net Income (TTM)
$34.38M
EPS (TTM)
$-0.00
P/E Ratio
-6.00
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$0.01
Volume
4,066,412
Open
$0.01
Price
$0.01
Volume
4,066,412
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.02
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$0.01
Volume
4,066,412
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.02
ATH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alterity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
David A. Stamler, MD
Website
www.alteritytherapeutics.comHeadquarters
Melbourne, VIC 3000, AU
ATH Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-47%
Return on Capital
-37%
Return on Assets
-26%
Earnings Yield
-16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$97.88M
Shares Outstanding
10.88B
Volume
4.07M
Short Interest
0.00%
Avg. Volume
7.71M
Financials (TTM)
Gross Profit
$5.31M
Operating Income
$14.57M
EBITDA
$14.63M
Operating Cash Flow
$11.45M
Capital Expenditure
$0.00
Free Cash Flow
$11.45M
Cash & ST Invst.
$40.66M
Total Debt
$155.46K
Alterity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$57.89K
-103.2%
Gross Margin
0.00%
N/A
Market Cap
$97.88M
N/A
Market Cap/Employee
$9.79M
N/A
Employees
10
N/A
Net Income
$9.62M
-47.8%
EBITDA
$13.00M
-56.0%
Quarterly Fundamentals
Net Cash
$49.04M
+306.4%
Accounts Receivable
$6.84M
+17.9%
Inventory
$0.00
N/A
Long Term Debt
$130.92K
+71.1%
Short Term Debt
$32.99K
-81.6%
Return on Assets
-25.63%
N/A
Return on Invested Capital
-37.08%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$10.62M
-136.3%